Comparison of the long-term clinical, metabolic, and economic outcomes of sleeve gastrectomy (SG) and roux-en-y gastric bypass (RYGB)
DOI:
https://doi.org/10.12775/QS.2025.48.66825Keywords
sleeve gastrectomy, Roux-en-Y gastric bypass, Obesity, metabolic surgery, long-term outcomes, cost-effectiveness, Type 2 Diabetes (T2D)Abstract
Introduction: Obesity is a chronic, multifactorial disease affecting over one billion people worldwide (WHO, 2025). It increases the risk of type 2 diabetes, cardiovascular diseases and certain cancers. Because conservative treatment has limited long-term efficacy, bariatric surgery, particularly Sleeve Gastrectomy (SG) and Roux-en-Y Gastric Bypass (RYGB), has become a key therapy for morbid obesity.
Aim: To compare long-term clinical, metabolic and cost-effectiveness outcomes of SG and RYGB
Materials and Methods: A literature review was conducted using PubMed, PMC, Google Scholar and ResearchGate, limited to English publications. The analysis included major randomized trials and cost-effectiveness studies, as well as WHO, IFSO and national guidelines.
Results: RYGB produced greater long-term weight loss, with %TWL higher by 3.6–4.9 percent, and higher diabetes remission (75 vs 61 percent at 1 year; 37 vs 27 percent at 10 years) compared with SG. It also more strongly improved insulin sensitivity and triglycerides, but carried an increased risk of nutritional deficiencies, mainly iron and vitamin B12, requiring lifelong supplementation. SG caused fewer nutritional issues but was associated with a higher incidence of GERD. Quality-of-life improvements measured by SF-36 and BAROS were similar. Cost analyses showed that RYGB, despite higher initial costs, leads to net savings within 5–10 years because of greater remission of metabolic comorbidities. Both Borisenko and Lauren confirmed its economic advantage in public health systems.
Conclusions: RYGB offers superior long-term metabolic benefits and cost-effectiveness, though with higher nutritional risk. SG remains a safe and effective option, especially for patients without severe metabolic disease or GERD. The choice of procedure should be individualized, considering metabolic benefit, nutritional risk and economic factors.
References
Angrisani, L., Santonicola, A., Iovino, P., et al. (2017). Bariatric surgery and endoluminal procedures: IFSO worldwide survey 2014. Obesity Surgery, 27(9), 2279–2289. https://doi.org/10.1007/s11695-017-2666-x
Arterburn, D., Wellman, R., Emiliano, A., Smith, S. R., Odegaard, A. O., Murali, S., Williams, N., Coleman, K. J., Courcoulas, A., Coley, R. Y., Anau, J., Pardee, R., Toh, S., Janning, C., Cook, A., Sturtevant, J., Horgan, C., & McTigue, K. M. (2018). Comparative effectiveness and safety of bariatric procedures for weight loss: A PCORnet cohort study. Annals of Internal Medicine, 169(11), 741–750.
Borisenko, O., Adam, D., Funch-Jensen, P., Ahmed, A. R., Zhang, R., Colpan, Z., & Hedenbro, J. (2015). Bariatric surgery can lead to net cost savings to health care systems: Results from a comprehensive European decision analytic model. Obesity Surgery, 25(9), 1559–1568. https://doi.org/10.1007/s11695-014-1567-5
Cecchini, M., Sassi, F., Lauer, J. A., Lee, Y. Y., Guajardo-Barrón, V., & Chisholm, D. (2010). Tackling of unhealthy diets, physical inactivity, and obesity: Health effects and cost-effectiveness. The Lancet, 376(9754), 1775–1784. https://doi.org/10.1016/S0140-6736(10)61514-0
Finucane, M. M., Stevens, G. A., Cowan, M. J., Danaei, G., Lin, J. K., Paciorek, C. J., Singh, G. M., Gutierrez, H. R., Lu, Y., Bahalim, A. N., Farzadfar, F., Riley, L. M., & Ezzati, M. (2011). National, regional, and global trends in body-mass index since 1980: Systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. The Lancet, 377(9765), 557–567. https://doi.org/10.1016/S0140-6736(10)62037-5
Gagner, M., Deitel, M., Erickson, A. L., & Crosby, R. D. (2013). Laparoscopic sleeve gastrectomy: Technique and outcomes. Surgery for Obesity and Related Diseases, 9(5), 709–712. https://doi.org/10.1016/j.soard.2013.02.013
GBD 2021 Risk Factor Collaborators. (2024). Global burden of 88 risk factors in 204 countries and territories, 1990–2021: A systematic analysis for the Global Burden of Disease Study 2021. The Lancet, 403, 2162–2203.
Gonzalez-Heredia, R., Patel, N., Sanchez-Johnsen, L., Masrur, M., Murphey, M., Chen, J., & Elli, E. (2015). Does age influence bariatric surgery outcomes? Bariatric Surgical Practice and Patient Care, 10(2), 74–78. https://doi.org/10.1089/bari.2015.0004
Guerreiro, V., Neves, J. S., Salazar, D., Ferreira, M. J., Oliveira, S. C., Souteiro, P., Pedro, J., Magalhães, D., Varela, A., Belo, S., Freitas, P., & Carvalho, D. (2019). Long-term weight loss and metabolic syndrome remission after bariatric surgery: The effect of sex, age, metabolic parameters, and surgical technique – A 4-year follow-up study. Obesity Facts, 12(6), 639–652. https://doi.org/10.1159/000503753
Hofsø, D., Fatima, F., Borgeraas, H., Birkeland, K. I., Gulseth, H. L., Hertel, J. K., Johnson, L. K., Lindberg, M., Nordstrand, N., Cvancarova Småstuen, M., Stefanovski, D., Svanevik, M., Gretland Valderhaug, T., Sandbu, R., & Hjelmesæth, J. (2019). Gastric bypass versus sleeve gastrectomy in patients with type 2 diabetes (Oseberg): A single-centre, triple-blind, randomised controlled trial. The Lancet Diabetes & Endocrinology, 7(12), 912–924. https://doi.org/10.1016/S2213-8587(19)30344-4
International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO). (2024). 9th IFSO Global Registry Report 2024. Naples, Italy: IFSO.
Jarosz, A., Białkowska, M., Bogdański, P., Cybulska, B., Dzięcioł, J., Frąckiewicz, J., et al. (2023). Obesity in adults: Position statement of the Polish Association for the Study on Obesity, Polish Association of Endocrinology, Polish Association of Cardiodiabetology, Polish Psychiatric Association, Section of Eating Disorders. Varia Medica, 7(2), 77–148.
Lauren, B. N., Lim, F., Krikhely, A., Taveras, E. M., Woo Baidal, J. A., Bellows, B. K., & Hur, C. (2022). Estimated cost-effectiveness of medical therapy, sleeve gastrectomy, and gastric bypass in patients with severe obesity and type 2 diabetes. JAMA Network Open, 5(2), e2148317. https://doi.org/10.1001/jamanetworkopen.2021.48317
Mahawar, K. K., Omar, I., Singhal, R., Aggarwal, S., Allouch, M. I., Alsabah, S. K., ... & Aminian, A. (2021). The first modified Delphi consensus statement on sleeve gastrectomy. Surgical Endoscopy, 35(3), 1097–1103.
Okunogbe A, Nugent R, Spencer G, Powis J, Ralston J, Wilding J. Economic impacts of overweight and obesity: current and future estimates for 161 countries. BMJ Glob Health. 2022 Sep;7(9):e009773. doi: 10.1136/bmjgh-2022-009773. PMID: 36130777; PMCID: PMC9494015.
Peterli, R., Wölnerhanssen, B. K., Peters, T., et al. (2018). Effect of laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y gastric bypass on weight loss in patients with morbid obesity: The SM-BOSS randomized clinical trial. JAMA, 319(3), 255–265. https://doi.org/10.1001/jama.2017.20897
Rosenthal, R. J., & International Sleeve Gastrectomy Expert Panel. (2012). International Sleeve Gastrectomy Expert Panel Consensus Statement: Best practice guidelines based on experience of >12,000 cases. Surgery for Obesity and Related Diseases, 8(1), 8–19. https://doi.org/10.1016/j.soard.2011.10.019
Salminen, P., Grönroos, S., Helmiö, M., et al. (2022). Effect of laparoscopic sleeve gastrectomy vs Roux-en-Y gastric bypass on weight loss, comorbidities, and reflux at 10 years in adult patients with obesity: The SLEEVEPASS randomized clinical trial. JAMA Surgery, 157(8), 656–666. https://doi.org/10.1001/jamasurg.2022.2229
Schauer, P. R., Bhatt, D. L., Kirwan, J. P., Wolski, K., Aminian, A., Brethauer, S. A., Navaneethan, S. D., Singh, R. P., Pothier, C. E., Nissen, S. E., & Kashyap, S. R. (2017). Bariatric surgery versus intensive medical therapy for diabetes: 5-year outcomes. The New England Journal of Medicine, 376(7), 641–651. https://doi.org/10.1056/NEJMoa1600869
World Health Organization (WHO). (2025). Obesity and overweight: Fact sheet. Geneva: World Health Organization.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Hubert Bołdys-Żegocki, Anna Karcz, Barbara Pająk , Oliwia Wróblewska , Małgorzata Dworniczak, Sofiya Salash, Aleksandra Romaniuk, Jakub Majewski , Maria Kaniecka, Artur Koza
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 23
Number of citations: 0
